• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about psilocybin therapy

Recent news which mentions psilocybin therapy

Kaya Holdings Advocates For Psilocybin As FDA Rejects MDMA For PTSD Treatment
August 14, 2024
Tickers KAYS NEWS
Tags psilocybin therapy Regulations Market News
From Benzinga
Utah Hospitals Will Soon Provide Psilocybin And MDMA Therapy For Mental Health Conditions
March 25, 2024
Tickers NEWS NUMIF
Tags Legal FDA MDMA Therapy
From Benzinga
Psyched: New Evidence Shows Psilocybin As Anxiety Therapy, Open-Source Learning For Therapists, Enveric's Licensing Deals And More
March 04, 2024
Tickers ATAI CMND CMPS CYBN
Tags Cannabis FDA PSIL
From Benzinga
Washington Doctor Vs. DEA For Lawful Use Of Psilocybin To Treat Terminally Ill Patients
February 14, 2024
Tickers NEWS
Tags Legal Benzinga Management
From Benzinga
Canadian At-Home Microdose Psilocybin Clinical Trial Finalized, Here Are The Details
March 31, 2023
Tags Markets Apex Labs Psychedelics
From Benzinga
Meth Use Disorder Tackled With Psilocybin: Clinical Trial Begins Patient Enrollment
March 28, 2023
Tickers RVVTF
Tags RVVTF psilocybin therapy News
From Benzinga
Canada's Ongoing Struggle For Access To Natural Psilocybin As A Therapeutic Nabs Business Support
February 15, 2023
Tickers TRUFF
Tags News psilocybin therapy Market News
From Benzinga
Canadian Psychedelics Company Launches Take-Home Psilocybin Trial For Some 300 Participants
February 01, 2023
Tags Benzinga Markets Global
From Benzinga
Virginia Psychedelics: Legalizing Medical Use Of Psilocybin Gets A Thumbs Down
January 20, 2023
Tags virginia Benzinga Psychedelics Legalization
From Benzinga
2023 Could Be Make Or Break For Psychedelics In Missouri, This GOP Lawmaker Is Pushing For Change
January 09, 2023
Tags Markets Psychedelics psilocybin therapy
From Benzinga
What Happened With Psychedelics In The Last Year? 11 Key News Items, The Sector's Performance & Takeaways
January 03, 2023
Tickers ATAI AWKNF CMND CMPS
Tags Treatment Resistant Depression Legal psilocybin therapy
From Benzinga
Oregon's Final Rules For Psilocybin Services Are Ready, Learn What To Expect
December 28, 2022
Tags Cannabis Regulations psilocybin therapy
From Benzinga
First-Ever Clinical Trial On Magic Mushroom Therapy For Autism's Genetic Cause Receives Approval
December 27, 2022
Tickers KONEF NMLSF
Tags Markets Benzinga Fragile X Syndrome
From Benzinga
Canada: Fed Guidelines For Psychedelic Therapy, Quebec Treatment Costs, Access And Magic Mushrooms Dispensaries
December 21, 2022
Tags Markets Psychedelic/Assisted Therapies Psychedelics
From Benzinga
Potential Road To At-Home Psychedelics Use Permits: Low Dosing's Positive Outcomes In Phase 1 Trial
December 12, 2022
Tags Markets Psychedelics psilocybin therapy
From Benzinga
Magic Mushrooms Tested For Treating Type II Bipolar Disorder, Check Out Results So Far
December 12, 2022
Tickers CMPS
Tags CMPS Small Cap Markets
From Benzinga
DEA's Consistent Denial Of Psilocybin Access For Terminally Ill Being Challenged Again
October 27, 2022
Tickers CSA DEA
Tags Legal Dr/ Sunil Aggarwal Psychedelics
From Benzinga
In Oregon You Can Get Trained To Be A Licensed Psilocybin Therapy Provider
October 07, 2022
Tags psilocybin therapy Market News News
From Benzinga
Cannabis & Psychedelics As Effective Adjunct Medicine To Breast Cancer Therapy? Studies Say Yes
September 30, 2022
Tags General Breast Cancer Therapy Nicole Di Monda
From Benzinga
Why Magic Mushrooms Are Emerging As Major Part Of Public Discourse: What Science Is Saying
September 22, 2022
Tickers CMPS
Tags smoking cessation alcohol addiction Anorexia Nervosa
From Benzinga
Why Magic Mushrooms Are Emerging As Major Part Of Public Discourse: The Legal Situation
September 19, 2022
Tags USDA Psychedelics Markets
From Benzinga
Major Psychedelics Firm Is Studying Magic Mushrooms To Treat Meth Addiction
September 16, 2022
Tickers RVVTF
Tags Benzinga Psilocin Pharma Corp Neurological Disorders
From Benzinga
Mindset Pharma Meets With UK Regulator: Is A Phase 1 Trial Getting Close?
September 14, 2022
Tickers MSSTF
Tags psilocybin therapy Market News News
From Benzinga
Psychedelics Companies Are Teaming Up To Offer Access Veterans
September 13, 2022
Tickers AWKNF RVLWF
Tags Markets Psychedelic Retreats Wake Network
From Benzinga
Cathie Wood's Psychedelics Fund ARK Analyzes The Sector's Present & Future And Likes What It Sees
September 06, 2022
Tickers ATAI
Tags Cathie Wood Markets Small Cap
From Benzinga
Study Finds Psilocybin Anti-Depression Effects Last At Least One Year
March 04, 2022
Tags Market News psilocybin therapy John Hopkins University
From Benzinga
The Case For Psilocybin Therapy And Depression
January 30, 2022
Tags Cannabis psilocybin therapy Market News
From Benzinga
ATAI Life Sciences Announces New Program To Discover Next-Generation Mental Health Treatments
January 27, 2022
Tickers ATAI
Tags psilocybin therapy Cannabis Market News
From Benzinga
Psilocybin Therapy Combined With SSRI Antidepressants Is Possible, COMPASS Study Confirms
December 13, 2021
Tickers CMPS
Tags psilocybin therapy News Cannabis
From Benzinga
Peter Thiel-Backed Psychedelic Start-Up, ATAI Life Sciences, Increases Stake In Compass Pathways
November 29, 2021
Tickers ATAI CMPS
Tags Regulations Market News psilocybin therapy
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap